This article provides a comprehensive framework for the cross-validation of lipidomic findings across different populations, a critical step for translating lipid biomarkers into clinical practice.
Diabetic microvascular complications, including kidney disease, retinopathy, and neuropathy, are major drivers of morbidity, yet their progression varies significantly among individuals.
This article provides a comprehensive analysis of targeted and untargeted lipidomics and their transformative role in diabetes research.
This article provides a comprehensive comparison of UHPLC-MS/MS against other established lipidomics platforms for researchers and drug development professionals.
The integration of lipidomics with machine learning is revolutionizing non-invasive diagnostic biomarker discovery for a wide range of diseases, including cancer, rheumatoid arthritis, and congenital conditions.
This article provides a comprehensive analysis of the distinct plasma lipidomic profiles that differentiate patients with diabetes mellitus (DM) from those with diabetes and comorbid hyperuricemia (DH).
This article provides a comprehensive roadmap for the validation of lipid biomarkers in diabetes research, addressing the critical gap between initial discovery and clinical application.
This article provides a comprehensive comparative analysis of lipidomic profiles in Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D), synthesizing recent findings from clinical studies to elucidate distinct pathophysiological...
This article provides a comprehensive guide for researchers and drug development professionals tackling the central challenge in lipidomics: achieving comprehensive coverage of complex lipidomes.
This article provides a systematic overview of modern strategies for lipid species identification using tandem mass spectrometry (MS/MS).